Chengdong Qin - Publications

HOXD10 promotes hepatocellular carcinoma progression by enhancing m6A methylation and activating the PI3K/AKT/mTOR pathway.

Journal: Journal of translational medicine

Published: January 23, 2026

Determination of strychnine in human serum by liquid chromatography tandem mass spectrometry

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: September 04, 2025

Postoperative upper limb edema and dysfunction generated by axillary node excision with or without axillary vein tributary preservation in breast cancer patients (PLEDGE-Surgery): a randomized controlled study.

Journal: International journal of surgery (London, England)

Published: May 29, 2025

Ferroptosis in TNBC: interplay with tumor-infiltrating immune cells and therapeutic implications.

Journal: Molecular and cellular biochemistry

Published: January 22, 2025

Roles of macrophages and monocytes in resistance to immunotherapy in breast cancers.

Journal: Postgraduate medical journal

Published: January 09, 2025

The potential benefits of radiotherapy in elderly patients with early-stage triple-negative breast cancer.

Journal: Frontiers in medicine

Published: November 09, 2024

Oncoplastic Breast-Conserving Surgery for Upper Inner Quadrant Breast Cancer Using Pedicled Pectoralis Major Myofascial Flap.

Journal: Cancer management and research

Published: May 24, 2024

Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Journal: Oncology research and treatment

Published: March 26, 2023

Tanshinone IIA promotes vascular normalization and boosts Sorafenib's anti-hepatoma activity via modulating the PI3K-AKT pathway.

Journal: Frontiers in pharmacology

Published: March 19, 2023

PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.

Journal: Frontiers in immunology

Published: December 02, 2022

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World.

Journal: Frontiers in oncology

Published: May 04, 2021

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience.

Journal: Cancer biology & therapy

Published: May 19, 2020